Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [125I]EYF as selective radioligands

Neuroscience

Volumn 115, Issue 2, 2002, Pages 349-361

  Gouarderes C ^a   Quelven, I ^a   Mollereau, C ^a   Mazarguil, H ^a   Rice, S Q J ^b   Zajac, J M ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Autoradiography; Neuropeptide FF; Rat; Receptor; Selective radioligands

Indexed keywords

NEUROPEPTIDE FF RECEPTOR; NEUROPEPTIDE FF2 RECEPTOR; NEUROPEPTIDE RECEPTOR; PANCREAS POLYPEPTIDE; RADIOLIGAND; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; BRAIN REGION; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CHO CELL; CONTROLLED STUDY; EMBRYO; HIPPOCAMPUS; HUMAN; HUMAN CELL; HYPOTHALAMUS; IN VITRO STUDY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SEPTUM PELLUCIDUM; SPINAL CORD DORSAL HORN; THALAMUS; THALAMUS NUCLEUS; THALAMUS PARAFASCICULAR NUCLEUS;

ANIMALS; AUTORADIOGRAPHY; BRAIN CHEMISTRY; CHO CELLS; CRICETINAE; HUMANS; IODINE RADIOISOTOPES; KIDNEY; MALE; OLIGOPEPTIDES; PROTEIN BINDING; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE; SPINAL CORD;

EID: 0037146655     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00419-0     Document Type: Article

References (38)

1. Aarnisalo A.A., Panula P. Neuropeptide FF-containing efferent projections from the medial hypothalamus of rat: a Phaseolus vulgaris leucoagglutinin study. Neuroscience. 65:1995;175-192.
2. Allard M., Zajac J.-M., Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system. Neuroscience. 49:1992;101-116.
3. Ballet S., Mauborgne A., Gouarderes C., Bourgoin A.S., Zajac J.M., Hamon M., Cesselin F. The neuropeptide FF analogue, 1DME, enhances in vivo met-enkephalin release from the rat spinal cord. Neuropharmacology. 38:1999;1317-1324.
4. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., Smith K.E., Tamm J.A., Boteju L.W., Lakhlani P.P., Raddatz R., Yao W.J., Ogozalek K.L., Boyle N., Kouranova E.V., Quan Y., Vaysse P.J., Wetzel J.M., Branchek T.A., Gerald C., Borowsky B. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J. Biol. Chem. 275:2000;39324-39331.
5. Bonnard E., Burlet-Schiltz O., Frances B., Mazarguil H., Monsarrat B., Zajac J., Roussin A. Identification of neuropeptide FF-related peptides in rodent spinal cord. Peptides. 22:2001;1085-1092.
6. Desprat C., Zajac J.M. Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain. Dev. Brain Res. 82:1994;118-126.
7. Dossin O., Mouledous L., Baudry X., Tafani J.A., Mazarguil H., Zajac J.M. Characterization of a new radioiodinated probe for the alpha2C adrenoceptor in the mouse brain. Neurochem. Int. 36:2000;7-18.
8. Dupouy V., Zajac J.M. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis. Regul. Pept. 59:1995;349-356.
9. Dupouy V., Zajac J.M. Neuropeptide FF receptors in rat brain: a quantitative light-microscopic autoradiographic study using [125I][D.Tyr1, (NMe)Phe3]NPFF. Synapse. 24:1996;282-296.
10. Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., Szekeres P.G., Evans N.A., Schmidt D.B., Buckley P.T., Dytko G.M., Murdock P.R., Milligan G., Groarke D.A., Tan K.B., Shabon U., Nuthulaganti P., Wang D.Y., Wilson S., Bergsma D.J., Sarau H.M. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J. Biol. Chem. 275:2000;25965-25971.
11. Fukusumi S., Habata Y., Yoshida H., Iijima N., Kawamata Y., Hosoya M., Fujii R., Hinuma S., Kitada C., Shintani Y., Suenaga M., Onda H., Nishimura O., Tanaka M., Ibata Y., Fujino M. Characteristics and distribution of endogenous RFamide-related peptide-1. Biochim. Biophys. Acta. 1540:2001;221-232.
12. Gelot A., Frances B., Roussin A., Latapie J.P., Zajac J.M. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice. Brain Res. 808:1998;166-173.
13. Gouarderes C., Jhamandas K., Sutak M., Zajac J.M. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br. J. Pharmacol. 117:1996;493-501.
14. Gouarderes C., Kar S., Zajac J.M. Presence of neuropeptide FF receptors on primary afferent fibres of the rat spinal cord. Neuroscience. 74:1996;21-27.
15. Gouarderes C., Mollereau C., Tafani J.A., Mazarguil H., Zajac J.M. [(125)I]EYF: a new high affinity radioligand to neuropeptide FF receptors. Peptides. 22:2001;623-629.
16. Gouarderes C., Roumy M., Advokat C., Jhamandas K., Zajac J.M. Dual localization of neuropeptide FF receptors in the rat dorsal horn. Synapse. 35:2000;45-52.
17. Hinuma S., Shintani Y., Fukusumi S., Iijima N., Matsumoto Y., Hosoya M., Fujii R., Watanabe T., Kikuchi K., Terao Y., Yano T., Yamamoto T., Kawamata Y., Habata Y., Asada M., Kitada C., Kurokawa T., Onda H., Nishimura O., Tanaka M., Ibata Y., Fujino M. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nature Cell Biol. 2:2000;703-708.
18. Kivipelto L. Ultrastructural localization of neuropeptide FF, a new neuropeptide in the brain and pituitary of rats. Regul. Pept. 34:1991;211-224.
19. Kivipelto L., Panula P. Central neuronal pathways containing FLFQPQRFamide-like (morphine-modulating) peptides in the rat brain. Neuroscience. 41:1991;137-148.
20. Kotani M., Mollereau C., Detheux M., Le Poul E., Brezillon S., Vakili J., Mazarguil H., Vassart G., Zajac J.M., Parmentier M. Functional characterization of a human receptor for neuropeptide FF and related peptides. Br. J. Pharmacol. 133:2001;138-144.
21. Laguzzi R., Nosjean A., Mazarguil H., Allard M. Cardiovascular effects induced by the stimulation of neuropeptide FF receptors in the dorsal vagal complex: an autoradiographic and pharmacological study in the rat. Brain Res. 711:1996;193-202.
22. Liu Q., Guan X.M., Martin W.J., McDonald T.P., Clements M.K., Jiang Q., Zeng Z., Jacobson M., Williams D.L. Jr., Yu H., Bomford D., Figueroa D., Mallee J., Wang R., Evans J., Gould R., Austin C.P. Identification and characterization of novel mammalian neuropeptide ff-like peptides that attenuate morphine-induced antinociception. J. Biol. Chem. 276:2001;36961-36969.
23. Malin D.H., Lake J.R., Fowler D.E., Hammond M.V., Brown S.L., Leyva J.E., Prasco P.E., Dougherty T.M. FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides. 11:1990;277-280.
24. Mauborgne A., Bourgoin S., Polienor H., Roumy M., Simonnet G., Zajac J.M., Cesselin F. The neuropeptide FF analogue, 1DMe, acts as a functional opioid autoreceptor antagonist in the rat spinal cord. Eur. J. Pharmacol. 430:2001;273-276.
25. Mazarguil H., Gouarderes C., Tafani J.M., Marcus D., Kotani M., Mollereau C., Roumy M., Zajac J.-M. Structure-activity relationships of neuropeptide FF: role of C-terminal regions. Peptides. 22:2001;1471-1478.
26. Mollereau C., Gouarderes C., Dumont Y., Kotani M., Detheux M., Doods H., Parmentier M., Quirion R., Zajac J.M. Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226. Br. J. Pharmacol. 133:2001;1-4.
27. Panula P., Aarnisalo A.A., Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog. Neurobiol. 48:1996;461-487.
28. Panula P., Kivipelto L., Nieminen O., Majane E.A., Yang H.-Y.T. Neuroanatomy of morphine-modulating peptides. Med. Biol. 65:1987;127-135.
29. Paxinos, G., Watson, C. (Eds.), 1998. The Rat Brain in Stereotaxic Coordinates. Academic, Sydney.
30. Perry S.J., Huang E.Y., Cronk D., Bagust J., Sharma R., Walker R.J., Wilson S., Burke J.F. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett. 409:1997;426-430.
31. Roumy M., Gouarderes C., Mazarguil H., Zajac J.M. Are neuropeptides FF and SF neurotransmitters in the rat? Biochem. Biophys. Res. Commun. 275:2000;821-824.
32. Roumy M., Zajac J.M. Effects of neuropeptide FF on intracellular Ca2+ in mouse spinal ganglion neurons. Eur. J. Pharmacol. 306:1996;291-295.
33. Roumy M., Zajac J.M. Neuropeptide FF, pain and analgesia. Eur. J. Pharmacol. 345:1998;1-11.
34. Roumy M., Zajac J.M. Neuropeptide FF receptors couple to a cholera toxin-sensitive G-protein in rat dorsal raphe neurones. Eur. J. Pharmacol. 417:2001;45-49.
35. Vilim F.S., Aarnisalo A.A., Nieminen M.L., Lintunen M., Karlstedt K., Kontinen V.K., Kalso E., States B., Panula P., Ziff E. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol. Pharmacol. 55:1999;804-811.
36. Yang H.Y., Fratta W., Majane E.A., Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. USA. 82:1985;7757-7761.
37. Zajac J.M. Neuropeptide FF: new molecular insights. Trends Pharmacol. Sci. 22:2001;63.
38. Zajac, J.M., Roques, B.P., 1989. Properties Required for Reversible and Irreversible Radiolabelled Probes for Selective Characterization of Brain Receptors and Peptidases by Autoradiography. Ellis Horwood/Wiley, Chichester.